Larry Frieders Headshot

 

 

 

sitemap

FDA TAKING AIM AT COMPOUNDERS... AGAIN

You probably heard the news. The FDA leveled another shot at compounding pharmacies on January 9th, 2008. (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01772.html ) - and AGAIN they were using their tired ideas about the safety of hormone replacement. No, they're not upset with the drug makers who use mare urine and chemistry to make substances that have never naturally been found in the human body. They are again voicing a concern that real human hormones are potentially harmful. It seems that something like this pops up every few months. Those who want to stop compounding pharmacists will do practically anything to make their point - even if their point is illogical or harmful.

We are referring to the hormone substances that are BIOlogically IDENTICAL to the ones we make in our own bodies (estrone, estradiol, estriol, progesterone, testosterone, cortisol, insulin, thyroid). 

Here's a snippet from the FDA website:

The FDA's action today does not target pharmacists who practice traditional pharmacy compounding and who do not make false or misleading claims about compounded products. Traditional pharmacy compounding typically involves preparation of a drug for an individual patient by a pharmacist in response to a valid prescription from a licensed practitioner. This compounding follows a practitioner's decision that his or her patient has a special medical need that cannot be met by FDA-approved drugs. The FDA's current view on human drug compounding is addressed in its compounding Compliance Policy Guide, available at http://www.fda.gov/cder/pharmcomp/default.htm

The FDA also responded today to a citizen petition from Wyeth (Madison, New Jersey) asking the FDA to take regulatory action against compounding pharmacy operations that produce compounded "BHRT" drugs. Other stakeholders, including healthcare providers and consumer groups, have also raised concerns about "BHRT" drugs.

Notice the short phrase, “…responded today to a citizen petition from Wyeth…”. In the end, this is NOT something the officials at FDA just dreamed up. They are responding – as they are expected to do – to a petition from a “citizen”, a drug maker; the one company most directly at risk when bioidentical hormones are preferred over their horse concoctions and chemical alternatives. The FDA, like most government oversight agencies, responds when there are complaints. In this situation the complaint comes from a drug maker, not a citizen who claims to have been harmed bioidentical hormones. We must keep in mind that the people at Wyeth are citizens and they have a right to file a complaint. In response to their complaint, someone has an obligation to respond to their complaint. In this case, the FDA has that obligation.

Wyeth has a stake in this argument and they have rights to file petitions, just like the rest of us. Now that it’s on the table again have the opportunity to respond again.

With or without long-term studies – funded by a drug company – logic and results are on the side of those of us who know the benefits of using a real hormone vs. one that comes from a horse. The FDA comments focus on estriol. Loyd V. Allen, Jr., Ph.D., R.Ph. has this comment about estriol;

Estriol is a component of the human body, has been commercially available in the past and has a USP monograph. This subject needs to be followed and special attention paid to ensure that the true facts are posted and to help ensure the rights of physicians to prescribe and patients to receive compounded HRT. As a reminder from last year, Human Hormone Replacement Therapy (Patterned after Human Insulin) may be an alternative.

I must also point out that one drug maker sells a product called CORTEF. It contains cortisol, or hydrocortisone – the exact adrenal hormone our bodies make. Other drug companies make levothyroxine (T4) and liothyronine (T3), both hormones that are identical to the thyroid hormones we make in our bodies.

If it is logical and accepted to use those “bioidentical” hormone products, why the big stink over estriol? It might have something to do with the potential loss in market share if estriol – a hormone that cannot be patented. What happens to the market for horse estrogens and synthetic compounds if estriol is accepted as a standard replacement? Good point.

If you’re concerned about bioidentical hormones the FDA has published a paper that you may review – all you need is a pdf reader on your computer. It can be found at http://www.fda.gov/consumer/updates/bioidenticals010908.pdf  While I agree with the factual content of this paper, I am unhappy about the “tone” of the writing. It seems to suggest a negative bias toward bioidentical hormone use. The writers are entitled to their opinion – and it shows in the paper. Many of us disagree with their opinion.

I conclude that the war between horse urine and synthetic hormones vs. bioidentical hormones continues. There are no universal conclusions. If there were the FDA wouldn’t be so ready to respond as they have.  The argument will continue until someone PROVES which approach is best. Until then we’ll have to rely on logic and positive outcomes from those who choose bioidentical hormones over the others. This topic will gain attention every so often – just so we don’t forget that Wyeth has a major stake in keeping people away from bioidentical hormone replacement.

I know what I mean when I use the word, BIOIDENTICAL. The FDA – with the urging of the aforementioned petitioner – says we shouldn’t use the term because it is not well defined. I “Googled” the word and got over 250,000 responses. At least a large number of us know what it means – even if the FDA and some drug makers don’t.

And here's a bonus today. Dr. Jeffrey Dach has done an outstanding job casting the light of truth on the latest FDA report. Please make time to click on the link below and read his excellent piece. 

Read Dr. Dach's article… or (http://jeffreydach.com/2008/01/11/fda-declares-war-on-bioidentical-hormones-by-jeffrey-dach-md.aspx) While you're there be sure to sign up for his newsletter.


HERE's the piece that caused me to write this article.